Postbiotics Market Size & Outlook, 2026-2034

Postbiotics Market Overview

The global postbiotics market size was valued at USD 146.43 million in 2025 and is estimated to reach USD 309.26 million by 2034, growing at a CAGR of 8.78% during the forecast period (2026–2034). The rising awareness of gut and immune health, the growing prevalence of digestive disorders, the increasing demand for stable and safe functional ingredients, and the expanding applications across food, dietary supplements, pharmaceuticals, cosmetics, and animal nutrition are key drivers accelerating market growth.

Key Market Trends & Insights

• North America held the largest market share, over 35% of the global market.
• Asia-Pacific is the fastest-growing region, with a CAGR of 9.23%.
• By source, the Yeast segmentis expected to witness the fastest CAGR of 97%.
• By function, the digestive segment held the highest market share of over 30%.
• By form, the Liquid segment is expected to witness the fastest CAGR of 87%.
• By application, the Functional foods and beverages segment held the highest market share of over 40%.
• The U.S. postbiotics market was valued at USD 43.34 million in 2024 and reached USD 47.27 million in 2025.

Source: Straits Research

Market Size & Forecast

• 2025 Market Size: USD 146.43 million
• 2034 Projected Market Size: USD 309.26 million
• CAGR (2026-2034): 8.78%
• North America: Largest market
• Asia-Pacific: Fastest-growing

Postbiotics are bioactive compounds produced during the fermentation of beneficial microorganisms, including inactivated cells, enzymes, peptides, and metabolites. Unlike live probiotics, they deliver health benefits without requiring microbial viability. Postbiotics are widely used in functional foods, dietary supplements, infant nutrition, animal feed, cosmetics, and pharmaceuticals. Their stability, safety profile, and consistent performance make them suitable for formulations targeting gut balance, metabolic health, skin wellness, and overall physiological support.

The market is driven by rising demand for scientifically backed functional ingredients, growing interest in preventive healthcare, and increased use of functional foods and supplements. Expanding applications in animal nutrition, skincare, and clinical nutrition are creating new growth avenues. Opportunities are emerging through clean-label formulations, expansion in emerging economies, and integration into mainstream food products. Moreover, advancements in fermentation technologies and supportive regulatory frameworks are enabling wider commercialization and cross-industry adoption.

Latest Market Trends

Growing shift from live probiotics to stable, non-viable bioactive compounds

The market is witnessing a clear shift from live probiotics toward stable, non-viable bioactive compounds, driven by concerns around product stability and safety. Unlike probiotics, postbiotics do not require strict storage conditions, making them more suitable for mass production and global distribution.

This transition is also supported by growing scientific evidence highlighting the consistent efficacy of postbiotics in gut health, immunity, and metabolic support. Manufacturers increasingly favor postbiotics for their longer shelf life, formulation flexibility, and ease of incorporation into functional foods, supplements, and clinical nutrition products.

Ongoing R&D focusing on standardization and efficacy validation

Research and development efforts in the global postbiotics market are increasingly centered on establishing standardized production processes and consistent quality benchmarks. Companies and research institutions are investing in controlled fermentation methods and precise characterization of bioactive components to ensure uniformity, safety, and reproducibility across postbiotic formulations.

Efficacy validation has become a key priority, with expanded clinical studies aimed at proving functional benefits across digestion, immunity, and inflammation management. This scientific validation is strengthening regulatory confidence and supporting wider adoption of postbiotics in pharmaceuticals, medical nutrition, and functional food applications.

To get more insights about this report Download Free Sample Report

Market Driver

Increasing global prevalence of digestive disorders and immune-related conditions

The postbiotics market is witnessing significant growth, driven by increasing consumer focus on preventive health and wellness. Rising awareness of the role of gut health in overall immunity is encouraging the adoption of functional ingredients that support digestive and immune functions.

• For instance, in 2025, irritable bowel syndrome (IBS) and other functional gastrointestinal disorders have shown significant increases, with IBS rates rising from about 4.7% to 6.0%, and functional dyspepsia from 8.3% to 11.9% compared before and after the COVID-19 pandemic, underscoring growing global digestive health challenges that fuel demand for solutions like postbiotics.

This trend is further amplified by the expansion of functional foods, supplements, and clinical nutrition, offering companies opportunities to develop targeted, science-backed postbiotic formulations to meet evolving consumer needs.

Market Restraint

Limited consumer awareness compared to probiotics and prebiotics

Despite their proven functional benefits, postbiotics remain relatively unfamiliar to a large segment of consumers when compared to probiotics and prebiotics. The concept of non-living bioactive compounds is often misunderstood, leading to hesitation in adoption and slower market penetration. This knowledge gap is further amplified by limited marketing efforts and minimal representation in mainstream health discussions. As a result, consumers tend to rely on more established gut health solutions, creating a barrier to wider acceptance and sustained demand growth for postbiotic-based products.

Market Opportunity

Product innovation opportunities in personalized nutrition and medical foods

The market presents significant opportunities in personalized nutrition and medical foods, driven by increasing consumer demand for targeted, science-backed wellness solutions. Companies are exploring innovations that combine postbiotics with functional ingredients to support specific health outcomes, including metabolic, digestive, and immune wellness.

• In February 2025, Resbiotic unveiled resM™ GLP‑1 Postbiotic, a physician-formulated supplement designed to enhance GLP‑1 levels, support gut health and metabolism, aid healthy weight management, reduce cravings, and promote balanced blood sugar, reflecting innovation in postbiotic-based metabolic wellness solutions.

This trend highlights the growing potential for tailored formulations in functional foods, dietary supplements, and clinical nutrition, creating new avenues for product development and market expansion globally.

Regional Analysis

North America’s market is dominant, with a market share of over 35%, driven by strong consumer awareness, advanced nutraceutical research, and early adoption of gut health innovations. The market benefits from established dietary supplement ecosystems, clinical validation of postbiotic efficacy, and rising demand for stable, shelf-ready functional ingredients. Manufacturers focus on science-backed formulations for immunity, digestive health, and metabolic support, while partnerships between food companies and biotech firms accelerate the commercialization of these products. Regulatory clarity, acceptance of premium pricing, and the growing use of postbiotics in functional foods, beverages, and medical nutrition collectively strengthen regional leadership and sustain long-term market expansion.

• The United States postbiotics market is shaped by companies such as ADM, Kerry Group, and Cargill, which are developing heat-stable bioactive compounds for supplements and functional foods. These players invest heavily in clinical research, precision fermentation, and scalable manufacturing to validate health claims.
• Canada’s market is driven by companies such as Lallemand Health Solutions and Bio-K Plus, which focus on clinically supported, clean-label postbiotic ingredients. These firms emphasize digestive health, immunity, and pediatric nutrition, leveraging strong academic-industry collaboration.

Asia-Pacific: Significantly Growing Region

The Asia-Pacific postbiotics market is the fastest-growing, with a CAGR of 9.23%, supported by rising health awareness, expanding middle-class populations, and strong demand for digestive wellness solutions. Growth is fueled by functional food innovation, the growing adoption of preventive healthcare, and the rapid commercialization of microbiome science. Manufacturers prioritize scalable fermentation, cost-efficient production, and integration of postbiotics into dairy, beverages, and traditional nutrition formats. Moreover, increased investments in research, local manufacturing, and distribution infrastructure enable faster market penetration, while consumer trust in science-backed wellness products continues to strengthen regional momentum across diverse consumer segments.

• China’s postbiotics market is expanding through companies such as Inner Mongolia Yili, BY-HEALTH, and Angel Yeast, with a focus on functional nutrition and gut health innovation. These players invest in large-scale fermentation, ingredient standardization, and application research.
• India’s market is gaining momentum with companies like Sun Pharma, Arjuna Natural, and Sami-Sabinsa exploring gut-health and immunity-focused formulations. These firms leverage botanical expertise, fermentation technology, and affordable production to develop stable postbiotic ingredients.

Source: Straits Research

Europe Market Trends

Europe’s postbiotics market is shaped by strong regulatory discipline, advanced food science, and deep integration of microbiome research into functional nutrition. The region emphasizes clinically validated, clean-label, and sustainably produced postbiotic ingredients, particularly for promoting digestive health, enhancing immunity, and supporting healthy aging. In addition, growth is supported by collaboration between research institutes, ingredient manufacturers, and food brands, enabling precise formulation and standardized efficacy. Postbiotics are increasingly used in dairy alternatives, medical nutrition, and infant food, reflecting Europe’s cautious yet science-driven consumer base.

• Germany’s market benefits from companies such as BASF Nutrition & Health and Symrise, which focus on precision fermentation and pharmaceutical-grade bioactives. These players invest in clinical validation, stability testing, and application research for functional foods and medical nutrition.

Latin America Market Trends

Latin America’s postbiotics market is evolving through rising health awareness, expanding functional food consumption, and growing interest in digestive and immune health. The region favors cost-effective, shelf-stable ingredients suited to warm climates and complex supply chains, making postbiotics particularly attractive. Food and beverage manufacturers are increasingly incorporating postbiotics into dairy products, fortified drinks, and nutritional supplements to meet the demands of urban consumers. According to Straits Research, growth is supported by improved regulatory frameworks, expanded local production capabilities, and a shift toward preventive nutrition.

• Brazil’s market is developing through companies such as Kerry’s regional operations and local nutraceutical manufacturers, focusing on functional dairy and beverage applications. These players emphasize scalable production and stability under high temperatures, supporting widespread distribution.

The Middle East and Africa Market Trends

The Middle East and Africa postbiotics market is driven by rising lifestyle-related health concerns, increasing adoption of functional nutrition, and demand for heat-stable, long-lasting ingredients. Postbiotics align well with the region’s climate conditions and import-dependent supply chains, supporting their use in supplements and fortified foods. Market growth is driven by urbanization, increasing healthcare awareness, and government initiatives promoting preventive health. Moreover, major manufacturers focus on immunity, digestive wellness, and metabolic health, positioning postbiotics as practical, science-led solutions across evolving nutrition ecosystems.

• Saudi Arabia’s market is expanding through healthcare-focused nutrition companies and international ingredient suppliers targeting immunity and metabolic health. Firms emphasize stable formulations suitable for functional beverages and supplements, aligned with the country’s preventive healthcare vision.

Source Insights

Bacteria-based postbiotics dominate the market, accounting for over 60% of the share, primarily due to their established role in modulating the gut microbiome and promoting overall digestive health. These postbiotics are widely incorporated into functional foods, beverages, and dietary supplements due to their proven efficacy, stability, and safety profile. Their continued adoption is driven by rising consumer awareness of gut health and the increasing integration of bacterial postbiotics in daily nutrition.

Yeast-derived postbiotics are the fastest-growing segment, expanding at a CAGR of 8.97%, due to their emerging applications in immune and skin health support. Yeast postbiotics are valued for their bioactive metabolites, which enhance the functionality and stability of products. Rising research highlighting their health benefits, along with increasing demand for innovative functional foods and nutraceuticals, supports rapid market adoption and positions this segment as a key driver of growth.

Function Insights

Digestive health-focused postbiotics hold a market share of over 30%, driven by their effectiveness in regulating bowel movements, reducing gastrointestinal discomfort, and supporting nutrient absorption. These postbiotics are extensively used in functional foods, beverages, and dietary supplements. Moreover, consumer preference for natural solutions to maintain digestive wellness ensures sustained demand, making digestive health a dominant application area in the postbiotics market.

Gut health-focused postbiotics are growing at a CAGR of 9.01%, reflecting increased awareness of the gut microbiome’s impact on overall wellness. These products help balance intestinal flora, strengthen the immune system, and enhance metabolic functions. Rising research and incorporation into functional foods and nutraceuticals drive adoption, as consumers increasingly seek products that promote holistic gut wellness and support preventive healthcare, fueling segment growth.

Form Insights

Dry postbiotics dominate the market, holding over 60% share, due to their longer shelf life, ease of storage, and suitability for incorporation into powdered functional foods, beverages, and supplements. The stable, concentrated nature of dry formulations ensures consistent dosing and performance. In addition, their compatibility with industrial processing and wide-ranging applications sustains their market leadership across the food, dietary supplement, and pharmaceutical industries.

Liquid postbiotics are the fastest-growing form segment, with a CAGR of 8.87%, driven by rising consumer preference for ready-to-consume health beverages and formulations. Liquid forms enable faster absorption, ease of mixing in functional drinks, and novel applications in skincare and nutraceuticals. Moreover, growth is fueled by innovation in stabilization technologies that preserve bioactivity and broaden the product range for health-conscious consumers.

Application Insights

Functional foods and beverages account for over 40% market share, remaining the largest application segment for postbiotics. These products harness the health-promoting properties of postbiotics to promote digestive and gut wellness. Integration into everyday consumables ensures high consumer accessibility and acceptance. The versatility of postbiotics in snacks, drinks, and dairy products maintains their dominance, with ongoing product innovation supporting continued market penetration.

Dietary supplements represent the fastest-growing application, expanding at a CAGR of 9.12%, driven by rising consumer interest in targeted health solutions. Postbiotic supplements offer convenience, precise dosing, and proven efficacy in gut, immune, and metabolic health. Growth is fueled by increasing awareness of preventive healthcare, personalized nutrition trends, and the incorporation of postbiotics into capsules, tablets, and powders, resulting in strong adoption among health-conscious consumers.

Source: Straits Research

Company Market Share

Leading firms are focusing on expanding their product portfolios and technological capabilities to meet the rising demand for digestive and immune health solutions. Many are investing in novel postbiotic ingredient development, clinical research, and scalable fermentation processes. Efforts include enhancing formulation stability, improving bioactivity, and tailoring products for specific applications such as functional foods, dietary supplements, and personal care. Strategic collaborations, expanded distribution networks, and regulatory compliance initiatives are also driving competitive market positioning.

ADM (Archer Daniels Midland Company)

ADM was established in 1902 in Decatur, Illinois, USA, originally focusing on grain storage and processing. Over the years, it has grown into a global leader in agricultural processing and food ingredients, specializing in oils, starches, proteins, and fermentation-based solutions. ADM operates in over 170 countries, providing ingredients and solutions for food, beverages, animal nutrition, and industrial applications, while emphasizing sustainability and innovation in agricultural and nutritional products.

List of key players in Postbiotics Market

1. Cargill, Incorporated
2. DuPont Nutrition & Health
3. ADM (Archer Daniels Midland Company)
4. Kerry Group plc
5. Probi AB
6. Hansen Holding A/S
7. Nestlé S.A.
8. Yakult Honsha Co., Ltd.
9. Morinaga Milk Industry Co., Ltd.
10. BioGaia AB
11. Novozymes A/S
12. Lesaffre Group
13. Sabinsa Corporation
14. Lallemand Inc.
15. DSM Nutritional Products
16. Arla Foods Ingredients Group
17. Evonik Industries AG
18. Ingredion Incorporated
19. BASF SE
20. POSTBIOTICA S.R.L.

To get more findings about this report Download Market Share

Recent Development

• October 2025 - Pharmachem Innovations announced the launch of its new GPM Biome Fermented Nutrients, featuring a clinically relevant dose of postbiotics, at SupplySide Global 2025. This offering provides enhanced nutrient absorption, as well as gut and immune support, in a clean-label ingredient format.
• March 2025 - Postbiotics Inc.’s patented gut-health postbiotic PoZibio® was selected as a winner in the Puratos Gut Health Innovation Challenge at Future Food-Tech 2025 in San Francisco, highlighting its potential to protect the gut lining and support overall digestive health — a key benefit for immune-related and inflammatory conditions.
• February 2025 - ADM and Asahi Group Foods signed an exclusive global distribution deal for the lactic acid-based postbiotic Lactobacillus gasseri CP2305, backed by eight human clinical trials, to support stress, mood, and sleep, expanding its availability to manufacturers in North America, Europe, and Asia in 2025.